Found 6 matching trials
A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects
PHASE1This study is a single-center, open-lable and fixed sequence test conducted...
Location
West China Hospital of Sichuan University
A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors
PHASE1This is an open-label, single-arm, multicenter, dose-escalation and dose-ex...
Location
Shanghai East Hospital
A Study to Evaluate the Mass Balance of [14C] SY-5007 in Healthy Adult Male Subjects in China
PHASE1This is a single-center, open-label, non-randomized, single dose study in h...
Location
Beijing Friendship Hospital, Capital Medical University
A Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects
PHASE1This study is a single-center, randomized, open-label, single-dose, two-per...
Location
West China Hospital of Sichuan University
Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC
PHASE3This is a phase III, open-label, single-arm, multicenter study designed to ...
Status
Active Not Recruiting
Location
Shanghai Pulmonary Hospital
Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor
PHASE1This is a phase I/II, open-label, multi-center, first-in-human study design...
Location
Shanghai Pulmonary Hospital